全文获取类型
收费全文 | 1767篇 |
免费 | 97篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 17篇 |
儿科学 | 12篇 |
妇产科学 | 26篇 |
基础医学 | 216篇 |
口腔科学 | 26篇 |
临床医学 | 154篇 |
内科学 | 473篇 |
皮肤病学 | 86篇 |
神经病学 | 124篇 |
特种医学 | 56篇 |
外科学 | 257篇 |
综合类 | 7篇 |
预防医学 | 78篇 |
眼科学 | 48篇 |
药学 | 131篇 |
中国医学 | 5篇 |
肿瘤学 | 180篇 |
出版年
2023年 | 9篇 |
2022年 | 13篇 |
2021年 | 36篇 |
2020年 | 26篇 |
2019年 | 24篇 |
2018年 | 41篇 |
2017年 | 32篇 |
2016年 | 51篇 |
2015年 | 59篇 |
2014年 | 52篇 |
2013年 | 98篇 |
2012年 | 147篇 |
2011年 | 117篇 |
2010年 | 75篇 |
2009年 | 64篇 |
2008年 | 129篇 |
2007年 | 136篇 |
2006年 | 149篇 |
2005年 | 127篇 |
2004年 | 101篇 |
2003年 | 105篇 |
2002年 | 95篇 |
2001年 | 12篇 |
2000年 | 7篇 |
1999年 | 10篇 |
1998年 | 21篇 |
1997年 | 12篇 |
1996年 | 16篇 |
1995年 | 15篇 |
1994年 | 16篇 |
1993年 | 8篇 |
1992年 | 14篇 |
1991年 | 5篇 |
1990年 | 5篇 |
1989年 | 7篇 |
1988年 | 8篇 |
1987年 | 6篇 |
1986年 | 4篇 |
1985年 | 8篇 |
1984年 | 7篇 |
1983年 | 4篇 |
1982年 | 5篇 |
1981年 | 5篇 |
1980年 | 3篇 |
1977年 | 2篇 |
1938年 | 1篇 |
1936年 | 1篇 |
1912年 | 1篇 |
1909年 | 2篇 |
1908年 | 1篇 |
排序方式: 共有1896条查询结果,搜索用时 78 毫秒
11.
Mouse TIMP-1, one of the tissue inhibitors of metalloproteinases important in regulating turnover of extracellular matrix in both normal and pathological tissues, was previously expressed inE. coli in an inactive, nonglycosylated state that required refolding to become functional. Due to the difficulty of renaturation, an alternative to the prokaryotic expression system was sought. Since we are interested in studying the pharmacodynamics and pharmacokinetics of TIMP locally administered by controlled delivery to mice with experimentally induced arthritis, we also needed an efficient way of producing active TIMP in large quantities. Using the pBlueBacII transfer vector, we generated a recombinant baculovirus that in Sf9 cells could express glycosylated mouse TIMP-1 to about 3 mg of active protein/liter conditioned medium. 相似文献
12.
Monica Rossi Enzo Ricci Luca Colantoni Giuliana Galluzzi Roberto Frusciante Pietro A Tonali Luciano Felicetti 《BMC medical genetics》2007,8(1):8
Background
The homologous 4q and 10q subtelomeric regions include two distinctive polymorphic arrays of 3.3 kb repeats, named D4Z4. An additional BlnI restriction site on the 10q-type sequence allows to distinguish the chromosomal origin of the repeats. Reduction in the number of D4Z4 repeats below a threshold of 10 at the 4q locus is tightly linked to Facioscapulohumeral Muscular Dystrophy (FSHD), while similar contractions at 10q locus, are not pathogenic. Sequence variations due to the presence of BlnI-sensitive repeats (10q-type) on chromosome 4 or viceversa of BlnI-resistant repeats (4q-type) on chromosome 10 are observed in both alleles. 相似文献13.
14.
15.
Maurizio Iaria Carlo Pellegrino Elena Cremaschi Enzo Capocasale Raffaele Dalla Valle Paolo Del Rio Carmelo Puliatti 《Transplantation proceedings》2021,53(3):1055-1057
BackgroundLymphatic disorders (LDs) are the most common minor complications after kidney transplantation (KT), with an incidence rate between 0.6% and 33.9%, which appears to be related to both surgical and medical factors. LDs mostly resolve spontaneously, but occasionally a surgical approach may be required.Materials and MethodsWe report our experience with 7 KT recipients who developed persistent lymphorrhea (>150 mL/24 h) between October 2017 and March 2019. All cases were treated as outpatients with parietal fistulectomy (PF). The fibrotic aponeurotic-cutaneous tract was thoroughly excised, and the residual aponeurotic defect was closed by watertight suturing. Serial abdominal ultrasounds (US) were carried out after the procedure.ResultsA small perirenal graft lymphocele of <2 cm was detected by US in all patients after 48 to 72 hours, without any evidence of either vascular or ureteral compression. During the subsequent scheduled US follow-up, lymphoceles did not increase in size, and additional interventions were not needed. Neither superficial nor deep surgical-site infections were recorded in such patients.ConclusionsPF was found to be a safe and effective minimally invasive approach for persistent lymphorrhea after KT. It could be easily performed with local anesthesia in a day surgery setting and did not require patient hospitalization. 相似文献
16.
Antonella Massari Massimo Gennarelli Elisa Menegazzo Antonio Pizzuti Vincenzo Silani Ismaele Mastrogiacomo Enzo Pagani Corrado Angelini Guglielmo Scarlato Giuseppe Novelli Bruno Dallapiccola 《Journal of neurology》1995,242(6):379-383
We have analysed the [AGC] expansion in leucocytes, muscle and sperm from 17 individuals affected by myotonic dystrophy (DM). Skeletal muscle showed a larger repeat number than leucocytes in the same patient. A similar degree of expansion was detected in differently affected muscles of a single patient. The germline mutation ( 350 repeats) was expanded in somatic cells of the progeny in all patients examined. Our results provide evidence of an early postzygotic instability of the [AGC] repeat in DM. 相似文献
17.
Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts 总被引:3,自引:0,他引:3
Oscar Cirioni Andrea Giacometti Davide Drenaggi Fausto Ancarani Giorgio Scalise 《European journal of epidemiology》1999,15(4):387-391
The pathogenicity of Blastocystis hominis is extensively debated in the medical literature. Therefore, we did a prevalence study to investigate the association between the presence of several intestinal parasites and gastrointestinal symptoms in diverse patient cohorts. The study population consisted of 1216 adults, including immunocompromised patients, institutionalized psychiatric or elder subjects, immigrants from developing countries, travellers to developing tropical countries and controls. Several variables for each risk group were considered. Stools specimens, collected in triplicate, were processed by the same technicians. Clinical data about each subject were provided by standardized questionnaires. The presence of gastrointestinal symptoms were related to the presence of any parasite. In addition, on the basis of microbiological results, five subgroups of subjects were evaluated. The results showed a high prevalence of parasites in all the risk groups. Immunocompromised status, recent arrival from developing countries and the presence of behavioural aberrations were significantly related to presence of parasites. B. hominis was the parasite most frequently detected in each studied group. B. hominis showed a significant correlation with gastrointestinal symptoms only when detected in the group including subjects with a severe immunodepression. Immunodepression seems to be a factor of primary importance of the pathogenic role of B. hominis. 相似文献
18.
19.
Obesity is a multifactorial, chronic disorder that has reached epidemic proportions in most industrialized countries and is threatening to become a global epidemic. Obese patients are at higher risk from coronary artery disease, hypertension, hyperlipidemia, diabetes mellitus, cancers, cerebrovascular accidents, osteoarthritis, restrictive pulmonary disease, and sleep apnoea. In particular, visceral fat accumulation is usually accompanied by insulin resistance or type 2 diabetes mellitus, hypertension, hypertriglyceridemia, high uremic acid levels, low high density lipoprotein (HDL) cholesterol to define a variously named syndrome or metabolic syndrome. Metabolic syndrome is now considered a major cardiovascular risk factor in a large percentage of population in worldwide. Both obesity and metabolic syndrome are particularly challenging clinical conditions to treat because of their complex pathophysiological basis. Indeed, body weight represents the integration of many biological and environmental components and relationships among fat and glucose tolerance or blood pressure are not completely understood. Efforts to develop innovative anti-obesity drugs, with benefits for metabolic syndrome, have been recently intensified. In general two distinct strategies can be adopted: first, to reduce energy intake; second, to increase energy expenditure. Here we review some among the most promising avenues in these two fields of drug therapy of obesity and, consequently, of metabolic syndrome. 相似文献
20.